Skip to main content

Eli Lilly Is A Potential Triple Threat

Eli Lilly reported stunning new efficacy data in obesity but there is a potential cardiac signal that needs to be watched.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.